ANT1 is reduced in sporadic inclusion body myositis

E. Barca, M. Aguennouz, A. Mazzeo, S. Messina, A. Toscano, G. L. Vita, S. Portaro, D. Parisi, C. Rodolico

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To investigate ANT1 and NF-κB expression in inclusion body myositis (IBM) muscle and to verify their possible roles in the pathogenesis of the disease, we collected muscle samples from five patients with IBM, polimyositis (PM) and controls. p65 form of NF-κB was analyzed using immunocytochemistry, Western blot and EMSA. Western blot of ANT1 was performed and confirmed by gene expression study. Mann-Whitney test was used for groups comparisons. NF-κB (p65) was found over-expressed both with western blot and EMSA, either in IBM or PM patients versus controls (p <0.01). Expression of ANT1 were lower in IBM samples versus both PM and controls (p <0.01). ANT1 reduction and NF-κB over-expression in IBM muscle could explain the lack of apoptosis in such disease. Normal ANT1 expression in PM could be related to the scarcity of mitochondrial abnormalities in the disease, but it could also suggest that these two conditions diverge in activating different anti-apoptotic pathways.

Original languageEnglish
Pages (from-to)217-224
Number of pages8
JournalNeurological Sciences
Volume34
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Inclusion Body Myositis
Western Blotting
Muscles
Immunohistochemistry
Apoptosis
Gene Expression

Keywords

  • ANT1
  • Apoptosis
  • NF-κB
  • PM
  • sIBM

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Cite this

Barca, E., Aguennouz, M., Mazzeo, A., Messina, S., Toscano, A., Vita, G. L., ... Rodolico, C. (2013). ANT1 is reduced in sporadic inclusion body myositis. Neurological Sciences, 34(2), 217-224. https://doi.org/10.1007/s10072-012-0976-2

ANT1 is reduced in sporadic inclusion body myositis. / Barca, E.; Aguennouz, M.; Mazzeo, A.; Messina, S.; Toscano, A.; Vita, G. L.; Portaro, S.; Parisi, D.; Rodolico, C.

In: Neurological Sciences, Vol. 34, No. 2, 02.2013, p. 217-224.

Research output: Contribution to journalArticle

Barca, E, Aguennouz, M, Mazzeo, A, Messina, S, Toscano, A, Vita, GL, Portaro, S, Parisi, D & Rodolico, C 2013, 'ANT1 is reduced in sporadic inclusion body myositis', Neurological Sciences, vol. 34, no. 2, pp. 217-224. https://doi.org/10.1007/s10072-012-0976-2
Barca E, Aguennouz M, Mazzeo A, Messina S, Toscano A, Vita GL et al. ANT1 is reduced in sporadic inclusion body myositis. Neurological Sciences. 2013 Feb;34(2):217-224. https://doi.org/10.1007/s10072-012-0976-2
Barca, E. ; Aguennouz, M. ; Mazzeo, A. ; Messina, S. ; Toscano, A. ; Vita, G. L. ; Portaro, S. ; Parisi, D. ; Rodolico, C. / ANT1 is reduced in sporadic inclusion body myositis. In: Neurological Sciences. 2013 ; Vol. 34, No. 2. pp. 217-224.
@article{5434cb0795e44b2ca497d8f73ccfd42d,
title = "ANT1 is reduced in sporadic inclusion body myositis",
abstract = "To investigate ANT1 and NF-κB expression in inclusion body myositis (IBM) muscle and to verify their possible roles in the pathogenesis of the disease, we collected muscle samples from five patients with IBM, polimyositis (PM) and controls. p65 form of NF-κB was analyzed using immunocytochemistry, Western blot and EMSA. Western blot of ANT1 was performed and confirmed by gene expression study. Mann-Whitney test was used for groups comparisons. NF-κB (p65) was found over-expressed both with western blot and EMSA, either in IBM or PM patients versus controls (p <0.01). Expression of ANT1 were lower in IBM samples versus both PM and controls (p <0.01). ANT1 reduction and NF-κB over-expression in IBM muscle could explain the lack of apoptosis in such disease. Normal ANT1 expression in PM could be related to the scarcity of mitochondrial abnormalities in the disease, but it could also suggest that these two conditions diverge in activating different anti-apoptotic pathways.",
keywords = "ANT1, Apoptosis, NF-κB, PM, sIBM",
author = "E. Barca and M. Aguennouz and A. Mazzeo and S. Messina and A. Toscano and Vita, {G. L.} and S. Portaro and D. Parisi and C. Rodolico",
year = "2013",
month = "2",
doi = "10.1007/s10072-012-0976-2",
language = "English",
volume = "34",
pages = "217--224",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "2",

}

TY - JOUR

T1 - ANT1 is reduced in sporadic inclusion body myositis

AU - Barca, E.

AU - Aguennouz, M.

AU - Mazzeo, A.

AU - Messina, S.

AU - Toscano, A.

AU - Vita, G. L.

AU - Portaro, S.

AU - Parisi, D.

AU - Rodolico, C.

PY - 2013/2

Y1 - 2013/2

N2 - To investigate ANT1 and NF-κB expression in inclusion body myositis (IBM) muscle and to verify their possible roles in the pathogenesis of the disease, we collected muscle samples from five patients with IBM, polimyositis (PM) and controls. p65 form of NF-κB was analyzed using immunocytochemistry, Western blot and EMSA. Western blot of ANT1 was performed and confirmed by gene expression study. Mann-Whitney test was used for groups comparisons. NF-κB (p65) was found over-expressed both with western blot and EMSA, either in IBM or PM patients versus controls (p <0.01). Expression of ANT1 were lower in IBM samples versus both PM and controls (p <0.01). ANT1 reduction and NF-κB over-expression in IBM muscle could explain the lack of apoptosis in such disease. Normal ANT1 expression in PM could be related to the scarcity of mitochondrial abnormalities in the disease, but it could also suggest that these two conditions diverge in activating different anti-apoptotic pathways.

AB - To investigate ANT1 and NF-κB expression in inclusion body myositis (IBM) muscle and to verify their possible roles in the pathogenesis of the disease, we collected muscle samples from five patients with IBM, polimyositis (PM) and controls. p65 form of NF-κB was analyzed using immunocytochemistry, Western blot and EMSA. Western blot of ANT1 was performed and confirmed by gene expression study. Mann-Whitney test was used for groups comparisons. NF-κB (p65) was found over-expressed both with western blot and EMSA, either in IBM or PM patients versus controls (p <0.01). Expression of ANT1 were lower in IBM samples versus both PM and controls (p <0.01). ANT1 reduction and NF-κB over-expression in IBM muscle could explain the lack of apoptosis in such disease. Normal ANT1 expression in PM could be related to the scarcity of mitochondrial abnormalities in the disease, but it could also suggest that these two conditions diverge in activating different anti-apoptotic pathways.

KW - ANT1

KW - Apoptosis

KW - NF-κB

KW - PM

KW - sIBM

UR - http://www.scopus.com/inward/record.url?scp=84879687919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879687919&partnerID=8YFLogxK

U2 - 10.1007/s10072-012-0976-2

DO - 10.1007/s10072-012-0976-2

M3 - Article

VL - 34

SP - 217

EP - 224

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 2

ER -